Healthcare Services

Eye melanoma market analysis (2026–2030)

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Eye Melanoma Market From 2026 To 2030?

The eye melanoma market size has experienced strong growth in recent years. It is projected to expand from $9.86 billion in 2025 to $10.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.4%. This historical growth can be credited to advancements in ocular imaging technologies, a rise in cancer awareness, the expansion of oncology treatment facilities, enhanced diagnostic capabilities, and improved survival outcomes.

The eye melanoma market is anticipated to experience robust expansion in the coming years, with its valuation projected to reach $15.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period can be primarily attributed to the emergence of innovative immunotherapies, the increasing embrace of precision oncology, advancements in genetic testing, heightened investment in research for rare cancers, and enhanced early screening initiatives. Key trends expected during this period involve a heightened emphasis on early cancer detection, the increasing utilization of targeted therapies and immunotherapies, a greater reliance on advanced ocular imaging techniques, the proliferation of specialized oncology centers, and intensified clinical research focused on rare eye cancers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report

What Major Factors Are Driving The Eye Melanoma Market Forward?

The escalating occurrence of eye cancer is anticipated to fuel the expansion of the eye melanoma market moving forward. Eye cancer involves the development of anomalous and unrestrained cell proliferation within the structures of the eye. The improved recognition and effective handling of early-stage instances are generating a greater requirement for specialized treatments and interventions, driven by enhanced diagnostic methods, increased awareness, and advancements in therapeutic options. For example, according to the American Cancer Society, a US-based non-profit organization, there were roughly 3,140 new cases of eye and orbital cancers (predominantly melanomas) in 2025, including 1,620 in males and 1,520 in females. Furthermore, approximately 490 deaths resulted from these cancers, comprising 270 males and 220 females. Thus, the growing prevalence of eye cancer is expected to stimulate the growth of the eye melanoma market.

Which Segments Define The Eye Melanoma Market Segment Structure?

The eye melanoma market covered in this report is segmented –

1) By Site: Uvea, Sclera, Retina

2) By Diagnosis: Imaging, Biopsy, Eye Exam

3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment

4) By End User: Hospitals And Clinics, Academic Institutes

Subsegments:

1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma

2) By Sclera: Episcleral Melanoma, Scleral Surface Melanoma, Conjunctival Melanoma

3) By Retina: Macular Melanoma, Peripheral Retinal Melanoma, Optic Disc Melanoma

Which Trends Are Impacting The Progress Of The Eye Melanoma Market?

Leading companies in the eye melanoma market are prioritizing the development of technological innovations, such as protein-kinase C (PKC) inhibitors, to meet the rising demand for effective systemic treatments that also help preserve the eye. PKC inhibitors are small-molecule compounds designed to block PKC enzymes involved in tumor growth, offering a non-surgical alternative to conventional treatments like plaque brachytherapy or enucleation. For example, in March 2025, IDEAYA Biosciences, a US-based precision oncology company, introduced darovasertib, a first-in-class PKC inhibitor specifically for uveal melanoma. This therapy targets PKC isoforms linked to tumor proliferation, with Phase 2 trials showing tumor shrinkage rates of around 82% and eye-preservation rates of 61%. Darovasertib provides a systemic, eye-sparing treatment option for patients eligible for either enucleation or plaque brachytherapy.

Who Are The Established Players Within The Eye Melanoma Market?

Major companies operating in the eye melanoma market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Amgen Inc., Castle Biosciences Inc., IDEAYA Biosciences Inc., Delcath Systems Inc., Immunocore Holdings plc, Aura Biosciences Inc., TriSalus Life Sciences Inc., Replimune Group Inc., Linnaeus Therapeutics, iOnctura, LES LABORATOIRES SERVIER, Immatics NV

Get The Full Eye Melanoma Market Report:

https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report

Which Region Represents The Largest Share Of The Eye Melanoma Market?

North America was the largest region in the eye melanoma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Eye Melanoma Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report

Browse Through More Reports Similar to the Global Eye Melanoma Market 2026, By The Business Research Company

Melanoma Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/melanoma-therapeutics-global-market-report

Melanoma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/melanoma-drugs-global-market-report

Malignant Melanoma Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malignant-melanoma-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795